Advertisement

Topics

Thrombolytic Science, LLC Company Profile

09:32 EST 22nd January 2019 | BioPortfolio

Thrombolytic Science, LLC (TSI) is a privately-held vascular health and biotechnology company leading development of a next-generation, life-saving therapy to transform traditional medical approaches for treating blood clots caused by ischemic stroke and heart attacks – interventions that have not changed in decades. The company’s vision is to bring clot-busting therapy directly to the patient quickly, especially following an ischemic stroke, rather than having a patient wait to get to a hospital. TSI's dual, sequential thrombolytic regimen was established based upon research at Tufts University School of Medicine and Harvard Medical School, where scientists designed HisproUK. For more information, follow TSI on Twitter @ThrombolyticSci and visit tsillc.net.


News Articles [456 Associated News Articles listed on BioPortfolio]

Delivery of thrombolytic treatment for stroke in Helsinki beats expectations

Neurologists around the world are aware that the delivery of thrombolytic treatment for stroke in Helsinki University Hospital, Finland, is freaking fast - but is it too fast?

Migraines Mimicking Stroke Still Pose Diagnostic Challenges

(MedPage Today) -- Migraine with aura responsible for 18% of improper thrombolytic treatments

Half-Dose Alteplase Is Associated with Escalation of Care in Pulmonary Embolism Patients

Half doses were associated with additional thrombolytic dosing or mechanical thrombectomy.

CSIR-IMTECH's thrombolytic protein acquired by Epygen

The Council of Scientific & Industrial Research's Institute of Microbial Technology in India and Epygen Biotech agreed to wor -More- 

Science and She: Dr. Barbara Mugwanya Zawedde

Science and She is an online campaign of the International Service for the Acquisition of Agri-biotech Applications (ISAAA) and its network of Biotechnology Information Centers which aims to empower w...

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

Study Seeks to Confirm Efficacy and Safety of Next-generation Clot-dissolving Therapy Consisting of Low-dose tPA and HisproUK Thrombolytic Science, LLC (TSI) today...

RGU and NHS Combine to Promote the Importance of Laboratory Science

RGU and NHS combine to promote the importance of laboratory science. Biomedical science staff from Robert Gordon University’s (RGU) School of Pharmacy and Life Sciences arepartnering with NHS Gr...

A New Edition of Public Understanding of Science Is Now Available

Public Understand of Science (vol. 27, no. 6, 2018) is available online by subscription only. Articles include: “Science to the Rescue or Contingent Progress? Comparing 10?Years of Public, Exper...

PubMed Articles [460 Associated PubMed Articles listed on BioPortfolio]

Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis.

BACKGROUND Pentraxin-3 (PTX3) is considered a high quality inflammatory marker of the severity and prognosis of several diseases, however, the value of PTX3 in thrombolytic therapy for acute ischemic ...

A case of cerebral infarction during a hemodialysis procedure successfully treated with recombinant tissue plasminogen activator.

Thrombolytic therapy is an effective treatment for acute ischemic stroke and provides benefits and improvements that lead to better neurological outcomes. However, thrombolytic therapy with recombinan...

Anesthetic Management of a Patient With Ongoing Thrombolytic Therapy During Decompressive Craniectomy: A Case Report.

Decompressive craniectomy (DC) is a therapeutic alternative for reducing intracranial pressure after a middle cerebral artery stroke. If thrombolytic therapy is administered, craniectomy is usually po...

The efficacy and safety of thrombolytic agents for patients with cerebral infarction: A protocol for systematic review and network meta-analysis.

Cerebral infarction is a commonly dangerous disease also with high morbidity and mortality. Thrombolytic agent is an effective method to treat it, but their relative efficacy and safety are unclear. A...

tPA Point Mutation at Autolysis Loop Enhances Resistance to PAI-1 Inhibition and Catalytic Activity.

Recombinant tissue-type plasminogen activator (r-tPA) was approved by U.S. Food and Drug Administration as a thrombolytic drug. However, a high dose of r-tPA (up to 100 mg/person) is typically used in...

Clinical Trials [327 Associated Clinical Trials listed on BioPortfolio]

Myocardial Infarction Triage and Intervention Project (MITI)

To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying...

Improving STEM Outcomes for Young Children With Language Learning Disabilities

The sophisticated language of science can be a barrier to Science, Technology, Engineering, and Math (STEM) learning, especially for children who have specific language impairment (SLI). T...

Cost Effectiveness if Primary PCI Versus Thrombolytic Therapy in Acute STEMI in Assiut University Hospital

Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients without contraindications

Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly

This is a prospective, randomized, multi-center, international trial comparing two reperfusion strategies in elderly (age >= 70 years) patients with acute myocardial infarction: primary p...

Rural CT Examination and Thrombolytic Treatment for Stroke

To counteract long term sequelae from stroke you need ultrarapid diagnosis and treatment, high quality multidiciplinary in-hospital care and optimal long term rehabilitation. In this study...

Companies [980 Associated Companies listed on BioPortfolio]

Thrombolytic Science, LLC

Thrombolytic Science, LLC (TSI) is a privately-held vascular health and biotechnology company leading development of a next-generation, life-saving therapy to transform traditio...

FirstScience.com

Welcome to FirstScience.com. We are a leading Internet Science site that offers visitors a chance to explore the world of science through great science content. FirstScience.com is a premier resource ...

Academy of Finland

The Academy of Finland provides funding for high-quality scientific research, serves as an expert in science and science policy, and strengthens the position of science and research.The Academy is com...

Science SPIN

Science SPIN is Ireland's first science magazine. But it's not just for scientists; it's for anyone with a fascination for finding out how and why.Find out how animals communicate ... why computers ar...

Vetex Medical

Vetex Medical is a privately-held company focused on making venous clot removal predictable, quick and cost-effective. The company’s first innovation – the Vetex Thrombe...

More Information about "Thrombolytic Science, LLC" on BioPortfolio

We have published hundreds of Thrombolytic Science, LLC news stories on BioPortfolio along with dozens of Thrombolytic Science, LLC Clinical Trials and PubMed Articles about Thrombolytic Science, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thrombolytic Science, LLC Companies in our database. You can also find out about relevant Thrombolytic Science, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...


Corporate Database Quicklinks



Searches Linking to this Company Record